Skip to content

Effect of Granisetron & Ondansetron on induced hypotension of spinal anesthesia

Comparison of the Prophylactic Effect Of Intravenous Ondansetron And Granisetron on Hypotension Induced Through Spinal Anesthesia in Cesarean Delivery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017061334519N1
Enrollment
210
Registered
2017-08-14
Start date
2017-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarian. Delivery by elective caesarean section

Interventions

Intervention 1: O intervention group: 4mg Ondansetron that diluted with 10cc saline normal is injecting intravenously 5 minutes before spinal anesthesia. Intervention 2: G group intervention: 1mg Gran
Treatment - Drugs
O intervention group: 4mg Ondansetron that diluted with 10cc saline normal is injecting intravenously 5 minutes before spinal anesthesia
G group intervention: 1mg Granisetron that diluted with 10cc saline normal is injecting intravenously 5minutes befor spinal anesthesia
control group: 10cc saline normal is injecting 5minutes befor spinal anesthesia

Sponsors

Vice chancellor for research, Zahedan Medical Science University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Pregnant women aged 18 to 45 with ASA class1,2 for elective cesarean section under spinal anesthesial. Exclusion criteria: coagulopathy; hemodynamic impaired; history of allergy to anesthesia or medication drugs are studied; taking SSRI anti-seizure & anti migraine; patients suffering from hypertensive disorder; any contraindication to spinal anesthesia; spinal anesthesia failure Open in Google Translate

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemodynamic condition. Timepoint: befor of intervension then every 3minutes to 20 minutes. Method of measurement: by monitor device.

Secondary

MeasureTime frame
Hypotension. Timepoint: befor intervention then every 3minute until 20 minutes. Method of measurement: by the monitor.;Bradicardia. Timepoint: befor intervention then every 3minute until 20 minutes. Method of measurement: by the monitor.;Nausea. Timepoint: when event. Method of measurement: patient complain.;Vomiting. Timepoint: when event. Method of measurement: patient complain.;Chill. Timepoint: when event. Method of measurement: patient complain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Marzieh Fadaei

Zahedan Medical Science University

m_fadaei1979@yahoo.com+98 54 3329 0475

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026